Clinicopathologic, Immunophenotypic, and Molecular Cytogenetic Fluorescence In Situ Hybridization Analysis of Primary and Secondary Cutaneous Follicular Lymphomas
暂无分享,去创建一个
U. Surti | S. Swerdlow | A. Pandya | M. Rabkin | Bong K Kim | Jack B. Cohen | Bong K. Kim | J. Cohen | M. S. Rabkin
[1] P. Batstone,et al. Extranodal follicular lymphoma: a clinicopathological and genetic analysis of 15 cases arising at non‐cutaneous extranodal sites , 2004, Histopathology.
[2] H. Kerl,et al. Differential Diagnosis of Cutaneous Infiltrates of B Lymphocytes with Follicular Growth Pattern , 2004, The American Journal of dermatopathology.
[3] G. Fleuren,et al. Bcl‐2, Bcl‐6 and CD10 expression in cutaneous B‐cell lymphoma: further support for a follicle centre cell origin and differential diagnostic significance , 2003, The British journal of dermatology.
[4] P. McKay,et al. Primary Cutaneous Diffuse Large B-cell Lymphoma: Prognostic Significance of Clinicopathological Subtypes , 2003, The American journal of surgical pathology.
[5] A. Nicholson,et al. Variable frequencies of t(11;18)(q21;q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma. , 2003, Blood.
[6] G. Wood,et al. Cutaneous lymphoid hyperplasia: a lymphoproliferative continuum with lymphomatous potential. , 2003, Human pathology.
[7] G. Ott,et al. T(14;18)(q32;q21) involving IGH and MALT1 is a frequent chromosomal aberration in MALT lymphoma. , 2003, Blood.
[8] U. Surti,et al. Primary and Secondary Cutaneous Diffuse Large B-Cell Lymphomas: A Multiparameter Analysis of 25 Cases Including Fluorescence In Situ Hybridization for t(14;18) Translocation , 2003, The American journal of surgical pathology.
[9] L. Staudt,et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. , 2003, Cancer cell.
[10] W. Chan,et al. The t(14;18) and bcl-2 expression are present in a subset of primary cutaneous follicular lymphoma: association with lower grade. , 2002, American journal of clinical pathology.
[11] P. McKay,et al. Primary Cutaneous Follicular Lymphoma A Clinicopathologic and Molecular Study of 16 Cases in Support of a Distinct Entity , 2002 .
[12] A. Rosenwald,et al. Cytomorphologic, immunohistochemical, and cytogenetic profiles of follicular lymphoma: 2 types of follicular lymphoma grade 3. , 2002, Blood.
[13] R. Gascoyne,et al. Primary cutaneous diffuse large B-cell lymphoma: a clinicopathologic study of 15 cases. , 2002, American journal of clinical pathology.
[14] R. Gascoyne,et al. Primary cutaneous follicular lymphoma: an assessment of clinical, histopathologic, immunophenotypic, and molecular features. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] H. Kerl,et al. Primary cutaneous lymphomas: applicability of current classification schemes (European Organization for Research and Treatment of Cancer, World Health Organization) based on clinicopathologic features observed in a large group of patients. , 2002, Blood.
[16] S. Whittaker,et al. Absence of the t(14; 18) chromosomal translocation in primary cutaneous B‐cell lymphoma: reply from authors , 2002, The British journal of dermatology.
[17] J. Taubenberger,et al. Cutaneous Follicle Center Lymphoma: A Clinicopathologic Study of 19 Cases , 2001, Modern Pathology.
[18] M. Piris,et al. Cutaneous Follicular B-Cell Lymphoma: Description of a Series of 18 Cases , 2001, The American journal of surgical pathology.
[19] N. Harris,et al. Cutaneous B-Cell Lymphomas of Follicular and Marginal Zone Types: Use of Bcl-6, CD10, Bcl-2, and CD21 in Differential Diagnosis and Classification , 2001, The American journal of surgical pathology.
[20] K. Franssila,et al. Causes and Consequences of BCL2 Overexpression in Diffuse Large B-Cell Lymphoma , 2001, Leukemia & lymphoma.
[21] S. Swerdlow,et al. Immunophenotypic and Genotypic Markers of Follicular Center Cell Neoplasia in Diffuse Large B-Cell Lymphomas , 2000, Modern Pathology.
[22] H. Kerl,et al. Primary cutaneous follicle center cell lymphoma with follicular growth pattern. , 2000, Blood.
[23] R. Tubbs,et al. Clinicopathologic reassessment of primary cutaneous B-cell lymphomas with immunophenotypic and molecular genetic characterization. , 2000, The American journal of surgical pathology.
[24] S. Pals,et al. Cell adhesion receptors in lymphoma dissemination. , 2000, Blood.
[25] S. Swerdlow,et al. Classification of small B-cell lymphoid neoplasms using a paraffin section immunohistochemical panel. , 2000, Applied immunohistochemistry & molecular morphology : AIMM.
[26] C. Meijer,et al. EORTC classification for primary cutaneous lymphomas: the best guide to good clinical management. European Organization for Research and Treatment of Cancer. , 1999, The American Journal of dermatopathology.
[27] D. Arber,et al. Frequency of bcl-2 expression in non-Hodgkin's lymphoma: a study of 778 cases with comparison of marginal zone lymphoma and monocytoid B-cell hyperplasia. , 1998, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[28] K. Franssila,et al. BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma. , 1997, Blood.
[29] R. Willemze,et al. Relation between expression of adhesion molecules and clinical behavior in cutaneous follicle center cell lymphomas. , 1997, Journal of the American Academy of Dermatology.
[30] H. Kerl,et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. , 1997, Blood.
[31] E. Noordijk,et al. Treatment of primary cutaneous B-cell lymphomas of follicle center cell origin: a clinical follow-up study of 55 patients treated with radiotherapy or polychemotherapy. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] R. Gascoyne,et al. Comparison of cytogenetic analysis, southern analysis, and polymerase chain reaction for the detection of t(14; 18) in follicular lymphoma. , 1995, American journal of clinical pathology.
[33] D. Slater. MALT and SALT: the clue to cutaneous B‐cell lymphoproliferative disease , 1994, The British journal of dermatology.
[34] P. Gaulard,et al. BCL2 gene activation and protein expression in follicular lymphoma: a report on 64 cases. , 1993, Leukemia.
[35] J. Rowley. Chromosome studies in the non-Hodgkin's lymphomas: the role of the 14;18 translocation. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] B. Osborne,et al. Follicular lymphoma mimicking progressive transformation of germinal centers. , 1987, American journal of clinical pathology.